| April Allen, FNP-C | |
|
706 Dixie St Ste 130, Carrollton, GA 30117-3859 | |
| (770) 812-5886 | |
| (770) 838-1027 |
| Full Name | April Allen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 706 Dixie St Ste 130, Carrollton, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194372532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN203733 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tanner Medical Center - Carrollton | Carrollton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanner Medical Group | 2769536143 | 98 |
News Archive
The Royal Australian College of General Practitioners' role in the development of practical strategies for risk management for Australian general practice has been highlighted in a report on the development of guidelines for the use of Implanon®.
A Dartmouth research laboratory is working to quantify the effects of playing games. In a study published online last month by the Games for Health Journal, Professor Mary Flanagan and her team found that attitudes toward public health issues shift to be more accepting and understanding after playing a game they developed called RePlay Health.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
Novel treatment strategies for major depression with broader treatment success or a more rapid onset of action would have immense impact on public health, a new study published in the December 1st issue of Biological Psychiatry explains.
The dynamics of the current COVID-19 pandemic could offer valuable insights for the efforts to mitigate climate change.
› Verified 8 days ago
| Entity Name | West Georgia Urology Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982701124 PECOS PAC ID: 6608762521 Enrollment ID: O20040226000310 |
News Archive
The Royal Australian College of General Practitioners' role in the development of practical strategies for risk management for Australian general practice has been highlighted in a report on the development of guidelines for the use of Implanon®.
A Dartmouth research laboratory is working to quantify the effects of playing games. In a study published online last month by the Games for Health Journal, Professor Mary Flanagan and her team found that attitudes toward public health issues shift to be more accepting and understanding after playing a game they developed called RePlay Health.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
Novel treatment strategies for major depression with broader treatment success or a more rapid onset of action would have immense impact on public health, a new study published in the December 1st issue of Biological Psychiatry explains.
The dynamics of the current COVID-19 pandemic could offer valuable insights for the efforts to mitigate climate change.
› Verified 8 days ago
| Entity Name | Tanner Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396979787 PECOS PAC ID: 2769536143 Enrollment ID: O20090819000657 |
News Archive
The Royal Australian College of General Practitioners' role in the development of practical strategies for risk management for Australian general practice has been highlighted in a report on the development of guidelines for the use of Implanon®.
A Dartmouth research laboratory is working to quantify the effects of playing games. In a study published online last month by the Games for Health Journal, Professor Mary Flanagan and her team found that attitudes toward public health issues shift to be more accepting and understanding after playing a game they developed called RePlay Health.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
Novel treatment strategies for major depression with broader treatment success or a more rapid onset of action would have immense impact on public health, a new study published in the December 1st issue of Biological Psychiatry explains.
The dynamics of the current COVID-19 pandemic could offer valuable insights for the efforts to mitigate climate change.
› Verified 8 days ago
| Entity Name | Ctca Physicians Group Of Georgia, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447520333 PECOS PAC ID: 4880841212 Enrollment ID: O20120820001117 |
News Archive
The Royal Australian College of General Practitioners' role in the development of practical strategies for risk management for Australian general practice has been highlighted in a report on the development of guidelines for the use of Implanon®.
A Dartmouth research laboratory is working to quantify the effects of playing games. In a study published online last month by the Games for Health Journal, Professor Mary Flanagan and her team found that attitudes toward public health issues shift to be more accepting and understanding after playing a game they developed called RePlay Health.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
Novel treatment strategies for major depression with broader treatment success or a more rapid onset of action would have immense impact on public health, a new study published in the December 1st issue of Biological Psychiatry explains.
The dynamics of the current COVID-19 pandemic could offer valuable insights for the efforts to mitigate climate change.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| April Allen, FNP-C 706 Dixie St Ste 220, Carrollton, GA 30117-3889 Ph: (770) 838-8710 | April Allen, FNP-C 706 Dixie St Ste 130, Carrollton, GA 30117-3859 Ph: (770) 812-5886 |
News Archive
The Royal Australian College of General Practitioners' role in the development of practical strategies for risk management for Australian general practice has been highlighted in a report on the development of guidelines for the use of Implanon®.
A Dartmouth research laboratory is working to quantify the effects of playing games. In a study published online last month by the Games for Health Journal, Professor Mary Flanagan and her team found that attitudes toward public health issues shift to be more accepting and understanding after playing a game they developed called RePlay Health.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
Novel treatment strategies for major depression with broader treatment success or a more rapid onset of action would have immense impact on public health, a new study published in the December 1st issue of Biological Psychiatry explains.
The dynamics of the current COVID-19 pandemic could offer valuable insights for the efforts to mitigate climate change.
› Verified 8 days ago
Sheila Reece Walls, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4248 Mount Zion Rd, Carrollton, GA 30117 Phone: 770-836-0103 Fax: 770-834-8828 | |
Latoya Pulliam Bexley, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 410 Dixie St, Carrollton, GA 30117 Phone: 678-796-0681 Fax: 770-836-8477 | |
Emilia Grace Janney, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 527 Tanner St, Carrollton, GA 30117 Phone: 770-537-1234 Fax: 770-537-1237 | |
Mr. Matthew Henderson, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 150 Clinic Ave Ste 101, Carrollton, GA 30117 Phone: 770-834-0873 | |
Ronda S Phillips, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 705 Dixie St, Suite 401, Carrollton, GA 30117 Phone: 770-838-8824 Fax: 770-838-8922 | |
Amy Hicks, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 104 Rome St, Carrollton, GA 30117 Phone: 404-301-4042 | |
Kelly R Thompson, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 705 Dixie St, Carrollton, GA 30117 Phone: 770-836-9666 Fax: 770-836-8922 |